<?xml version="1.0" encoding="UTF-8" ?>

       <rss version="2.0">

       <channel>

          <title>NewsVoir</title>

          <link>http://newsvoir.com</link><item>		

		 <title><![CDATA[2024 in Review: Innovations, Milestones, and Industry Leadership Across Sectors and What to Look Forward to in 2025  ]]></title>

		 <link>http://newsvoir.com/index.php?option=com_content&amp;view=release&amp;rid=30689</link>

		 <description><![CDATA[
	As 2024 draws the curtain, it's time to look back at the year of transformative achievements and forward-thinking innovation across industries. While the year was full of changes and new policies, each industry witnessed dynamism in the most progressive format possible. Setting new benchmarks and....]]></description>

		 <pubDate><![CDATA[Mon, 30 Dec 2024 12:38:05]]></pubDate>

		 </item><item>		

		 <title><![CDATA[Tech, Taxes and Transformation, at the Centre of Pre-Budget Expectations Across Sectors ]]></title>

		 <link>http://newsvoir.com/index.php?option=com_content&amp;view=release&amp;rid=23194</link>

		 <description><![CDATA[
	The annual Union Budget scheduled to be announced on February 1st, 2023, is expected to be growth oriented focusing on technological advancement, widespread allocation of resources, bridging the digital divide and addressing the security concerns of the virtual world. While many believe that the ....]]></description>

		 <pubDate><![CDATA[Tue, 31 Jan 2023 10:51:45]]></pubDate>

		 </item><item>		

		 <title><![CDATA[Academic Research Scholar Dr. Kannan Vishwanatth was Conferred Honorary Professorship at University of California, Berkeley]]></title>

		 <link>http://newsvoir.com/index.php?option=com_content&amp;view=release&amp;rid=20068</link>

		 <description><![CDATA[
	(Prof) Dr. Kannan Vishwanatth, noted academic researcher & Founder & Managing Director of Hong Kong based Rupus Global Limited, a globally acclaimed research-focused vertically integrated pharmaceutical Company, which contract manufactures active pharmaceutical ingredients (APIs), finished dosage....]]></description>

		 <pubDate><![CDATA[Sat, 16 Apr 2022 06:36:43]]></pubDate>

		 </item><item>		

		 <title><![CDATA[Bidding Farewell to 2021: An Ode to the Year Gone By]]></title>

		 <link>http://newsvoir.com/index.php?option=com_content&amp;view=release&amp;rid=18942</link>

		 <description><![CDATA[
	As we bid Adieu to 2021, there is undoubtedly a lot to reminisce. It has indeed been a year full of challenges, a chance to reflect and reimagine goals. Businesses over the last year have adopted to the new normal and designed their strategies enabling them to finally take a breath of fresh air.....]]></description>

		 <pubDate><![CDATA[Fri, 31 Dec 2021 09:30:50]]></pubDate>

		 </item>

</channel>

</rss>